Use access key #2 to skip to page content.
$0.33 0.02 (6.45%)
8/29/2008 4:00 PM

Zila, Inc. (ZILA)

CAPS Rating:
No stars

The Company is a specialty pharmaceutical company focused on the prevention and treatment of oral cancer.

View All Commentary (ZILA)

Recs

0

Avatar Hollykins (< 20) Submitted: 2/02/07 5:13 PM : Outperform Start Price: $2.21 ZILA Score: -74.07

There is a good chance FDA will approve
Oratest cancer detection product for dental care market this year. There are other larger potential markets that look very promising that could follow along.

Report this Post Replies: 1 | Reply

Avatar 1poorguy (96.52) Submitted: 2/17/07 8:38 PM

Recs: 0 | Rec This

I used to own this one. I finally bailed because management couldn't submit the proper data to the FDA. No, I'm not kidding. Their first Oratest submission was rejected because they didn't gather the data properly. Duh!! I think the product has potential, but I've been totally unimpressed with how management has run this project and this company. That's why I still have never bought back in. I called this one an underperform, and I believe I'm still the score leader for this stock.

Report this Post Reply

Featured Broker Partners